Scarica l'app Stockscreener
5.44
6.46%
0.33
Pre-mercato:
5.44
Precedente Chiudi:
$5.11
Aprire:
$5.19
Volume 24 ore:
90,196
Relative Volume:
0.60
Capitalizzazione di mercato:
$72.12M
Reddito:
$52.29M
Utile/perdita netta:
$-73.52M
Rapporto P/E:
-8.2424
EPS:
-0.66
Flusso di cassa netto:
$-100.45M
1 W Prestazione:
+8.80%
1M Prestazione:
-34.38%
6M Prestazione:
+9.46%
1 anno Prestazione:
-23.49%
Intervallo 1D:
$5.1101
$5.44
Intervallo di 1 settimana:
$4.8601
$5.44
Portata 52W:
$3.61
$8.82
Precision Biosciences Inc Stock (DTIL) Company Profile
Nome
Precision Biosciences Inc
Settore
Industria
Telefono
919-314-5512
Indirizzo
302 EAST PETTIGREW STREET, DURHAM, NC
Confronta DTIL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
5.44 | 123.01M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | Iniziato | Guggenheim | Buy |
| 2022-06-17 | Iniziato | BMO Capital Markets | Outperform |
| 2022-06-09 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | Ripresa | BTIG Research | Buy |
| 2020-04-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-03-05 | Iniziato | Stifel | Buy |
| 2020-02-25 | Iniziato | William Blair | Outperform |
| 2019-08-09 | Iniziato | BTIG Research | Buy |
| 2019-07-16 | Iniziato | H.C. Wainwright | Buy |
| 2019-04-22 | Iniziato | Barclays | Overweight |
| 2019-04-22 | Iniziato | Goldman | Buy |
| 2019-04-22 | Iniziato | JP Morgan | Overweight |
| 2019-04-22 | Iniziato | Jefferies | Buy |
Mostra tutto
Precision Biosciences Inc Borsa (DTIL) Ultime notizie
How Precision BioSciences Inc. stock compares to industry benchmarksJuly 2025 Levels & Daily Momentum Trading Reports - BỘ NỘI VỤ
Will Precision BioSciences Inc. stock outperform Nasdaq indexJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - moha.gov.vn
United StatesMintz Advises On Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mondaq
H.C. Wainwright Keeps Their Buy Rating on Precision BioSciences (DTIL) - The Globe and Mail
Will Precision BioSciences Inc. stock return to pre crisis levelsLayoff News & Growth Focused Stock Reports - newser.com
Detecting price anomalies in Precision BioSciences Inc. with AIFed Meeting & Technical Confirmation Alerts - newser.com
How analysts rate Precision BioSciences Inc. stock todayMarket Sentiment Report & High Accuracy Swing Entry Alerts - newser.com
Will Precision BioSciences Inc. stock outperform Dow Jones indexAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com
Will Precision BioSciences Inc. (PBS0) stock beat revenue estimates2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Mintz Advises on Precision BioSciences, Inc.’s $75 Million Registered Direct Offering - Mintz
Precision BioSciences (DTIL) Price Target Decreased by 10.55% to 33.15 - MSN
How Precision BioSciences Inc. (PBS0) stock compares with market leaders2025 Momentum Check & Daily Stock Trend Reports - newser.com
Is Precision BioSciences Inc. stock dividend yield sustainableWeekly Risk Summary & Real-Time Chart Pattern Alerts - newser.com
Is Precision BioSciences Inc. (PBS0) stock a contrarian opportunity2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Precision BioSciences Inc. (DTIL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why pension funds invest in Precision BioSciences Inc. (PBS0) stock2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Precision BioSciences (Nasdaq: DTIL) to Present PBGENE-HBV Trial Data at Hep-DART 2025 - Stock Titan
Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025 - Business Wire
Is Precision BioSciences Inc. (PBS0) stock in buy zone after pullback - newser.com
Genome Editing Market Research Report 2025-2032Industry - openPR.com
How hedge fund analytics apply to Precision BioSciences Inc. stock2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Multi asset correlation models including Precision BioSciences Inc.July 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com
Can Precision BioSciences Inc. stock resist market sell offsJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Is Precision BioSciences Inc. stock positioned well for digital economy2025 Pullback Review & Weekly Market Pulse Alerts - newser.com
Real time breakdown of Precision BioSciences Inc. stock performanceIndex Update & Accurate Entry/Exit Alerts - newser.com
Has Precision BioSciences Inc. found a price floorPortfolio Value Report & Reliable Price Breakout Alerts - newser.com
Precision Biosciences Inc Azioni (DTIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Precision Biosciences Inc Azioni (DTIL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kelly John Alexander | Chief Financial Officer |
Nov 03 '25 |
Sale |
6.49 |
1,303 |
8,456 |
77,298 |
| Scimeca Dario | General Counsel and Secretary |
Nov 02 '25 |
Option Exercise |
0.00 |
1,835 |
0 |
28,923 |
| Scimeca Dario | General Counsel and Secretary |
Nov 03 '25 |
Sale |
6.49 |
665 |
4,316 |
28,258 |
| Amoroso Michael | President and CEO |
Nov 02 '25 |
Option Exercise |
0.00 |
9,444 |
0 |
118,984 |
| Amoroso Michael | President and CEO |
Nov 03 '25 |
Sale |
6.49 |
3,409 |
22,124 |
115,575 |
0.45%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):